BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 38471823)

  • 1. Obesity, Galectin-3, and Incident Heart Failure: The ARIC Study.
    Florido R; Kwak L; Echouffo-Tcheugui JB; Zhang S; Michos ED; Nambi V; Goldberg RB; Hoogeveen RC; Lazo M; Gerstenblith G; Post WS; Blumenthal RS; Coresh J; Folsom AR; Selvin E; Ballantyne C; Ndumele CE
    J Am Heart Assoc; 2022 May; 11(9):e023238. PubMed ID: 35491999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth Differentiation Factor (GDF)-15 and Cardiometabolic Outcomes among Older Adults: The Atherosclerosis Risk in Communities Study.
    Echouffo-Tcheugui JB; Daya N; Matsushita K; Wang D; Ndumele CE; Al Rifai M; Hoogeveen RC; Ballantyne CM; Selvin E
    Clin Chem; 2021 Mar; 67(4):653-661. PubMed ID: 33582779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-Year Changes in Physical Activity and the Risk of Incident Heart Failure: ARIC Study.
    Florido R; Kwak L; Lazo M; Nambi V; Ahmed HM; Hegde SM; Gerstenblith G; Blumenthal RS; Ballantyne CM; Selvin E; Folsom AR; Coresh J; Ndumele CE
    Circulation; 2018 May; 137(20):2142-2151. PubMed ID: 29386202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of Diabetes and Incident Heart Failure: The ARIC (Atherosclerosis Risk In Communities) Study.
    Echouffo-Tcheugui JB; Zhang S; Florido R; Hamo C; Pankow JS; Michos ED; Goldberg RB; Nambi V; Gerstenblith G; Post WS; Blumenthal RS; Ballantyne CM; Coresh J; Selvin E; Ndumele CE
    JACC Heart Fail; 2021 Aug; 9(8):594-603. PubMed ID: 34325890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and Progression of Heart Failure: The Atherosclerosis Risk In Communities (ARIC) Study.
    Echouffo-Tcheugui JB; Ndumele CE; Zhang S; Florido R; Matsushita K; Coresh J; Skali H; Shah AM; Selvin E
    J Am Coll Cardiol; 2022 Jun; 79(23):2285-2293. PubMed ID: 35680178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of Cigarette Smoking and Heart Failure in Adults ≥65 Years of Age (From the Cardiovascular Health Study).
    Gottdiener JS; Buzkova P; Kahn PA; DeFilippi C; Shah S; Barasch E; Kizer JR; Psaty B; Gardin JM
    Am J Cardiol; 2022 Apr; 168():90-98. PubMed ID: 35045935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3, Metabolic Risk, and Incident Heart Failure: The ARIC Study.
    Echouffo-Tcheugui JB; Zhang S; Florido R; Pankow JS; Michos ED; Goldberg RB; Nambi V; Gerstenblith G; Post WS; Blumenthal RS; Ballantyne CM; Coresh J; Selvin E; Ndumele CE
    J Am Heart Assoc; 2024 Mar; 13(6):e031607. PubMed ID: 38471823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.
    Ndumele CE; Matsushita K; Sang Y; Lazo M; Agarwal SK; Nambi V; Deswal A; Blumenthal RS; Ballantyne CM; Coresh J; Selvin E
    Circulation; 2016 Feb; 133(7):631-8. PubMed ID: 26746175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex and Race Differences in N-Terminal Pro-B-type Natriuretic Peptide Concentration and Absolute Risk of Heart Failure in the Community.
    Myhre PL; Claggett B; Yu B; Skali H; Solomon SD; Røsjø H; Omland T; Wiggins KL; Psaty BM; Floyd JS; Selvin E; Ballantyne CM; Shah AM
    JAMA Cardiol; 2022 Jun; 7(6):623-631. PubMed ID: 35476049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community.
    Ho JE; Liu C; Lyass A; Courchesne P; Pencina MJ; Vasan RS; Larson MG; Levy D
    J Am Coll Cardiol; 2012 Oct; 60(14):1249-56. PubMed ID: 22939561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial.
    Sharma A; Vaduganathan M; Ferreira JP; Liu Y; Bakris GL; Cannon CP; White WB; Zannad F
    J Am Heart Assoc; 2020 Jan; 9(1):e012797. PubMed ID: 31902327
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.